Discovery Pipeline

Pfizer Teams up with Evotec on Drug Discovery

July 11, 2024

Through a multi-year collaboration, Pfizer and Evotec aim to conduct early discovery research for therapeutics against metabolic and infectious diseases.

Early Analytics with PDC Modeling and Translational CROs (BIO 2024)

June 07, 2024

Andrew Carnegie of Inaphaea BioLabs explains the role of a translational CRO and of PDC models in drug discovery.

Exploring the use of AI in R&D at the US Pharma and Biotech Summit

May 17, 2024

Regeneron’s Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, gave insight into how the biopharma industry views the application of AI in R&D.

Quantum-Si Launches Platform Enhancements for Protein Sequencer

February 06, 2024

The addition of another amino acid recognizer as well as improvements in surface chemistry, reagents, and software expand the proteome coverage of Quantum-Si’s Platinum sequencing platform.

Regeneron Forms R&D Cell Therapy Unit from 2seventy bio Platform Acquisition

February 01, 2024

With the formation of the new R&D unit, Regeneron will assume full development and commercialization rights to 2seventy bio’s preclinical- and clinical-stage cell therapy pipeline.

Daiichi Sankyo Partners with Depixus to Accelerate RNA-Targeted Drug Discovery

December 20, 2023

Under a collaboration, Daiichi Sankyo and Depixus will use Depixus’ MAGNA technology to accelerate drug discovery efforts of RNA-targeted therapeutics.

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

December 08, 2023

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

December 08, 2023

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

Genentech and NVIDIA Form AI Research Collaboration for Drug Discovery and Development

November 29, 2023

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.

Salipro Biotech and Icosagen to Collaborate on Antibody Discovery

October 12, 2023

Salipro Biotech and Icosagen have entered into a multi-target collaboration to discover and characterize monoclonal antibodies.